Bertrand Loy Harvard Bioscience Inc (HBIO) insider trading activity

Bertrand Loy is Director of HARVARD BIOSCIENCE INC. Currently has a direct ownership of 56,575 shares of HBIO, which is worth approximately $157,278. The most recent transaction as insider was on May 21, 2024, when has been sold 56,575 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.6K

0% 3M change

28.39% 12M change

Total Value Held $157,278

BERTRAND LOY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 21 2024	BUY Grant, award, or other acquisition	-	56,575 Added 50.0%	56,575 Common Stock
May 22 2023	BUY Grant, award, or other acquisition	-	31,516 Added 28.51%	79,009 Common Stock
Aug 26 2022	BUY Open market or private purchase	$31,682 $3.41 p/Share	9,291 Added 2.27%	399,651 Common Stock
Aug 25 2022	BUY Open market or private purchase	$27,535 $3.34 p/Share	8,244 Added 2.07%	390,360 Common Stock
Aug 24 2022	BUY Open market or private purchase	$55,850 $3.23 p/Share	17,291 Added 4.33%	382,116 Common Stock
Aug 23 2022	BUY Open market or private purchase	$28,873 $3.23 p/Share	8,939 Added 2.39%	364,825 Common Stock
Aug 22 2022	BUY Open market or private purchase	$15,541 $3.16 p/Share	4,918 Added 1.36%	355,886 Common Stock
Aug 19 2022	BUY Open market or private purchase	$31,514 $3.28 p/Share	9,608 Added 2.66%	350,968 Common Stock
Aug 18 2022	BUY Open market or private purchase	$3,672 $3.19 p/Share	1,151 Added 0.34%	341,360 Common Stock
May 24 2022	BUY Grant, award, or other acquisition	-	47,493 Added 12.25%	340,209 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	4,489 Added 1.51%	292,716 Common Stock
Dec 28 2021	BUY Grant, award, or other acquisition	-	1,401 Added 0.48%	288,227 Common Stock
May 25 2021	BUY Grant, award, or other acquisition	-	14,400 Added 4.78%	286,826 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	21,300 Added 7.25%	272,426 Common Stock

Also insider at

ENTG

ENTEGRIS INC Technology

President & CEO

Bertrand Loy

Director

Billerica, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Harvard Bioscience Inc insider buys or sells HBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HARVARD BIOSCIENCE INC

Track Activities on HBIO

Account